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Pulmonary Valve Regurgitation Caused
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Manoj Kesarwani, MD, Thomas A. Ports, MD, Rajni K. Rao, MD, Vaikom S. Mahadevan, MBBS, MDT ranscatheter heart valve implantation is awell-established alternative to surgical valvereplacement for speciﬁc types of valvular
heart disease (1–4). We report the ﬁrst case of im-
plantation of an Edwards SAPIEN XT transcatheter
heart valve (Edwards Lifesciences, Irvine, California)
in the native pulmonary valve position through a
tricuspid valve bioprosthesis to treat severe pulmo-
nary valve regurgitation as a result of carcinoid heart
disease.
A 77-year-old woman with carcinoid syndrome
that was due to grade 2 neuroendocrine tumor
was referred to the cardiology clinic for further
evaluation of severe lower extremity edema and
heart murmur. Investigations revealed right heart
failure as a result of carcinoid heart disease
with severe tricuspid and moderate-to-severe pul-
monary valve regurgitation. Coronary angiography
also demonstrated an 80% proximal left anterior
descending coronary artery stenosis. Therefore, the
patient was referred to surgery for valve replace-
ment of both the tricuspid and pulmonary valves
with concomitant coronary artery bypass graft
surgery. Surgical evaluation indicated that double-
valve surgery with single-vessel coronary artery
bypass graft surgery would be risk prohibitive,
and tricuspid valve replacement alone may beFrom the Department of Medicine, Division of Cardiology, University of
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tidisciplinary team discussion, the patient un-
derwent end-to-side grafting of the left internal
mammary artery onto the left anterior descending
coronary artery and placement of a 25-mm Carpentier-
Edwards bioprosthesis (Edwards Lifesciences) in the
tricuspid position.
Because of persistent symptoms of right heart
failure 1 month following surgery, percutaneous
placement of an Edwards SAPIEN XT valve in the
pulmonic position with transesophageal echocardi-
ography guidance was pursued. Transfemoral venous
access was obtained, and the tricuspid valve bio-
prosthesis was crossed with a balloon-tipped pul-
monary artery catheter. The pulmonary valve was
then traversed with the same catheter and posi-
tioned in a segmental branch of the left pulmonary
artery, which was thereafter exchanged for a curved
tip Lunderquist extra-stiff wire (Cook Medical,
Bloomington, Indiana). A pulmonary angiogram
was performed (Figure 1, Online Video 1). The pul-
monary valve annulus was sized with a 24-mm
Amplatzer sizing balloon (St. Jude Medical, St.
Paul, Minnesota) (Figure 2, Online Video 2). This
was followed by direct implantation of a 26-mm
Edwards SAPIEN XT valve in the pulmonic posi-
tion, which resulted in an excellent angiographicCalifornia, San Francisco, San Francisco School of
s Lifesciences. All other authors have reported that
.
FIGURE 2 Amplatzer Sizing Balloon Across the
Pulmonary Valve
Inﬂated 24-mm Amplatzer sizing balloon across the pulmonary
valve with residual waist, indicated by the red arrow
(Online Video 2).
FIGURE 3 Pulmonary Angiogram After Implantation of
the Edwards SAPIEN XT Valve
Pulmonary angiogram following implantation of the Edwards
SAPIEN XT valve in the pulmonic position, with trivial
catheter-induced pulmonary regurgitation (Online Video 3).
FIGURE 1 Pulmonary Angiogram Conﬁrming Severe
Pulmonary Valve Regurgitation
A Multi-Track angiography catheter (NuMed Inc., Hopkinton,
New York) is positioned distal to the pulmonary valve over a
curved tip Lunderquist extra-stiff wire (Cook Medical), which
is placed distally in a segmental branch of the left pulmonary
artery (Online Video 1). The 25-mm Carpentier-Edwards
tricuspid valve bioprosthesis is also visualized.
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e162appearance with trivial catheter-induced pulmonary
regurgitation and a well-functioning tricuspid valve
bioprosthesis (Figure 3 Online Video 3). Two weeks
later, the patient was discharged to a rehabilitation
facility with much improved peripheral edema
and stable renal function, after a brief period of
continuous venovenous hemodialysis because of
anuria.
In patients who are considered excessively high
risk for surgical valve replacement, transcatheter
heart valve implantation with an Edwards SAPIEN
XT valve can be safely performed in the pulmonic
position through an existing tricuspid valve bio-
prosthesis. In this particular instance, pre-stenting
of the right ventricular outﬂow tract before
transcatheter pulmonic valve implantation was not
performed, because carcinoid accretion of the
native pulmonary valve provided an adequate
landing zone for deployment of the new valve
bioprosthesis.
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